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ABSTRACT The human malaria parasite Plasmodium falciparum requires efﬁcient
egress out of an infected red blood cell for pathogenesis. This egress event is highly
coordinated and is mediated by several signaling proteins, including the plant-like P.
falciparum calcium-dependent protein kinase 5 (PfCDPK5). Knockdown of PfCDPK5
results in an egress block where parasites are trapped inside their host cells. The
mechanism of this PfCDPK5-dependent block, however, remains unknown. Here, we
show that PfCDPK5 colocalizes with a specialized set of parasite organelles known as
micronemes and is required for their discharge, implicating failure of this step as the
cause of the egress defect in PfCDPK5-deﬁcient parasites. Furthermore, we show
that PfCDPK5 cooperates with the P. falciparum cGMP-dependent kinase (PfPKG)
to fully activate the protease cascade critical for parasite egress. The PfCDPK5-
dependent arrest can be overcome by hyperactivation of PfPKG or by physical dis-
ruption of the arrested parasite, and we show that both treatments facilitate the re-
lease of the micronemes required for egress. Our results deﬁne the molecular
mechanism of PfCDPK5 function and elucidate the complex signaling pathway of
parasite egress.
IMPORTANCE The signs and symptoms of clinical malaria result from the replica-
tion of parasites in human blood. Efﬁcient egress of the malaria parasite Plasmodium
falciparum out of an infected red blood cell is critical for pathogenesis. The P. falci-
parum calcium-dependent protein kinase 5 (PfCDPK5) is essential for parasite egress.
Following PfCDPK5 knockdown, parasites remain trapped inside their host cell and
do not egress, but the mechanism for this block remains unknown. We show that
PfCDPK5 colocalizes with parasite organelles known as micronemes. We demonstrate
that PfCDPK5 is critical for the discharge of these micronemes and that failure of
this step is the molecular mechanism of the parasite egress arrest. We also show
that hyperactivation of the cGMP-dependent kinase PKG can overcome this arrest.
Our data suggest that small molecules that inhibit the egress signaling pathway
could be effective antimalarial therapeutics.
KEYWORDS Plasmodium falciparum, calcium-dependent protein kinase, egress,
malaria, microneme
Malaria remains an important cause of global morbidity and mortality with anestimated 214 million cases and 438,000 deaths in 2015 (1). Most of these deaths
are due to infection by the Plasmodium falciparum parasite. The emergence and spread
of drug resistance, particularly of artemisinin-resistant parasites in southeastern Asia (2),
threaten to limit the usefulness of antimalarial therapies. Therefore, there is an ongoing
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need to identify additional critical biological pathways that might be targeted by a new
generation of antimalarial medications.
The major clinical manifestations of malaria result from exponential expansion of
parasites during the blood stage of the life cycle (3–5). Asexual blood-stage develop-
ment of Plasmodium parasites occurs via schizogony. In this process, multiple asyn-
chronous nuclear divisions occur within a common cytoplasm. Mature and invasive
merozoites are not formed until a ﬁnal segmentation (or budding) wherein the newly
formed daughter parasites are all formed simultaneously. Thus, the daughter merozo-
ites are not fully mature until all daughter merozoites are mature (6). This requirement
highlights the importance of a coordinated egress signaling pathway to prevent release
of immature parasites.
In apicomplexan organisms, including both Plasmodium spp. and Toxoplasma gon-
dii, release of specialized apical organelles known as micronemes is a critical step in
parasite egress. The triggered discharge of these organelles depends on the activation
of calcium signaling, cGMP signaling, and phosphatidic acid signaling (7–10). Some of
the protein mediators of microneme discharge have been identiﬁed, including calcium-
dependent protein kinases (7, 11), C2 domain-containing proteins (12), and acylated
pleckstrin homology domain-containing proteins (10). However, the speciﬁc roles
played by these proteins in the activation of microneme discharge remain incompletely
understood.
Calcium-dependent protein kinases (CDPKs) (13–15) and the cyclic GMP-dependent
protein kinase (PKG) (8, 16, 17) are important for P. falciparum egress. Additionally, a
protease cascade mainly driven by the serine protease P. falciparum SUB1 (PfSUB1) is
essential for egress (8, 18, 19). P. falciparum PKG (PfPKG) activity is required for PfSUB1
release from specialized exoneme organelles (8), and once discharged into the parasi-
tophorous vacuole, PfSUB1 proteolytically processes multiple parasite proteins, includ-
ing the P. falciparum merozoite surface protein-1 (PfMSP1), which itself is essential for
egress and allows PfMSP1 to interact with and destabilize the host erythrocyte cyto-
skeleton (20). An important role for the perforin-like protein PfPLP1 in blood-stage
parasite egress has been hypothesized (21). However, PfPLP1 can be knocked out in the
blood stage without a detectable replication defect, suggesting that its role is nones-
sential and/or redundant for asexual parasite egress (22). PfCDPK5 (PF3D7_1337800) is
essential for P. falciparum egress (15). However, the mechanism behind the egress block
in PfCDPK5-deﬁcient parasites has remained unknown.
In the current study, we perform a functional evaluation of the egress defect in
PfCDPK5-deﬁcient parasites. With superresolution microscopy, we demonstrate the
dynamic localization of PfCDPK5 throughout schizogony and its colocalization with a
subset of microneme organelles. We show that PfCDPK5-deﬁcient parasites do not
efﬁciently release a subset of micronemes and that this failure of microneme release is
the cause of the egress block. In response to baseline activation of PfPKG, PfCDPK5-
deﬁcient parasites initially show activation of the protease cascade that is similar to
parasites without PfCDPK5 deﬁciency. However, this level of PfPKG activation is insuf-
ﬁcient to induce the release of the required subset of micronemes for egress, and
protease processing does not efﬁciently proceed to completion in PfCDPK5-deﬁcient
schizonts. Pharmacological enhancement of PfPKG activation facilitates microneme
release and overcomes the PfCDPK5-mediated deﬁciency. Interestingly, mechanical
release of PfCDPK5-deﬁcient merozoites also overcomes this block. We demonstrate
that a major function of PfCDPK5 is to act cooperatively with the PfPKG signaling
pathway. Our study provides a new layer in our understanding of the P. falciparum
egress pathway.
RESULTS
PfCDPK5 has dynamic localization during schizont development. We generated
a new transgenic P. falciparum strain, 3D7-PfCDPK5DDKnL, with three copies of the
hemagglutinin (HA) epitope followed by the destabilizing domain (DD) at the endog-
enous PF3D7_1337800 locus (Fig. 1A; also see Fig. S1 in the supplemental material). By
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placing the DD at the carboxy terminus of P. falciparum calcium-dependent protein
kinase 5 (PfCDPK5), the resulting fusion protein is rapidly degraded when the stabilizing
agent Shield-1 (Shld-1) is removed. As expected, when grown in the absence of Shld-1,
these parasites have a 90% schizont-stage replication defect in the second cycle
(Fig. 1A). These parasites also have a single copy of the mycobacteriophage Bxb1 attB
sequence (23). To allow quantitative measurement of egress following parasitophorous
vacuolar membrane (PVM) and red blood cell (RBC) plasma membrane rupture, we
integrated an attP-containing nano-luciferase reporter cassette into this attB site (24,
25). By fusing the ﬁrst 60 amino acids from the knob-associated histidine-rich protein,
the nano-luciferase reporter protein (referred to as KnL) is targeted via the secretory
system to the parasitophorous vacuole (26). In parasite cultures grown with Shld-1 ([]
Shld-1), bioluminescence accumulates in the cell pellet during asexual development
FIG 1 Characterization of 3D7-PfCDPK5DDKnL parasites and PfCDPK5 localization. (A, top) Schematic of 3D7-PfCDPK5DDKnL regulation. This parasite strain has
two genetic modiﬁcations. The destabilizing domain (DD) is fused to the carboxy terminus of PfCDPK5, and the KnL reporter gene is integrated into the genome.
The PfCDPK5 fusion protein is stabilized in the presence of Shld-1 and degraded in the absence of Shld-1. (Bottom left) Replication curves of 3D7-PfCDPK5DDKnL
and control 3D7 parasites cultured with Shld-1 ([] Shld-1) and without Shld-1 ([] Shld-1). Values are means  standard deviations (SD) (error bars) (n  3).
(Bottom right) Immunoblot of schizont-stage lysates probed with anti-HA (recognizes the epitope tag of PfCDPK5-3HA-DD) and anti-PfLDH (loading control).
The positions of molecular mass markers (in kilodaltons) are indicated to the left of the blot. h.p.i., hours post-invasion. (B) Schematic of KnL reporter protein
release from 3D7-PfCDPK5DDKnL parasites. The graph shows bioluminescent activity in supernatant and parasite pellets from ring, trophozoite, schizont, and
reinvaded parasites. Values are means  SD (n  3). (C) Schizonts from [] Shld-1 3D7-PfCDPK5DDKnL parasites were ﬁxed, probed with anti-HA and
anti-PfAMA1 antibodies, and visualized by SR-SIM. Bars, 2 m.
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and is released into the supernatant following egress (Fig. 1B). Thus, parasite biomass
can be quantiﬁed by bioluminescence in cultured cell pellet, and egress is monitored
by release of the KnL into the cell-free supernatant.
To evaluate the localization of PfCDPK5 during the asexual life cycle of P. falciparum,
we utilized superresolution structured illumination microscopy (SR-SIM). Parasites were
tightly synchronized, and at 44 h post-invasion (h.p.i.), schizonts were treated with E64,
a cysteine protease inhibitor that prevents egress but still allows maturation of viable
merozoites (26–28). Samples were collected for immunoﬂuorescence analysis (IFA) by
SR-SIM at ~48  2 h.p.i. For an internal “timer” for parasite maturation, we monitored
the expression and localization of the P. falciparum apical membrane antigen-1
(PfAMA1) (29–31). Consistent with previous studies of PfAMA1, we initially detected
PfAMA1 expression in the micronemes and after a poorly characterized “egress trigger,”
observed PfAMA1 translocation to the plasma membrane of the fully mature daughter
merozoites (8, 32, 33). In 3D7-PfCDPK5DDKnL parasites with undetected PfAMA1 ex-
pression, we observed punctate cytoplasmic localization of PfCDPK5 (Fig. 1C, top row).
In parasites with detected micronemal PfAMA1 localization, we observed two different
staining patterns for PfCDPK5. The ﬁrst was observed in parasites with weaker PfCDPK5
staining, where there was strong colocalization with micronemal PfAMA1 (Fig. 1C,
second row). Given that PfCDPK5 has no known signal sequence, we hypothesize that
it is located on the cytoplasmic side of these micronemes. In the second pattern,
observed at higher levels of PfCDPK5 expression, PfCDPK5 retained colocalization with
PfAMA1 but also exhibited additional diffuse apical staining (Fig. 1C, third row). In
parasites that were beyond the “egress trigger,” PfAMA1 was translocated to the
merozoite surface, and PfCDPK5 relocalized to a peripheral cytoplasmic distribution
with increased signal near the plasma membrane (Fig. 1C, E64-treated row). Localiza-
tion was similar in free merozoites isolated from parallel cultures grown without E64
(Fig. 1C, Free merozoite row). Complete z-stacks for a representative parasite from each
localization type are provided (see Movies S1 to S5 in the supplemental material). To
verify that PfCDPK5 was localized inside the cytoplasm of “post-egress trigger” mero-
zoites, we costained the parasites with antibodies directed against the PfGAP45 protein
associated with the inner membrane complex (34) and conﬁrmed that PfCDPK5 stain-
ing is located within PfGAP45 staining (Fig. S2A). This result demonstrates that PfCDPK5
is located within the parasite cytoplasm.
Previous reports have identiﬁed specialized apical organelles, including the PfSUB1-
containing exoneme (18) and the PfROM1-containing mononeme (35), that do not
overlap with classic micronemes, rhoptries, and dense granules. In order to further
identify the localization of PfCDPK5, we costained parasites with markers directed
against proteins in the rhoptries and micronemes. Results from SR-SIM showed that
PfCDPK5 did not consistently colocalize with the rhoptry neck marker PfRON4 (36) or
the exoneme marker PfSUB1 (Fig. S2B). However, we note that there are limited areas
of overlap between PfCDPK5 and all of the tested apical organelle markers, mostly
observed when PfCDPK5 had strong expression levels. Given the strong colocalization
with PfAMA1-containing micronemes, we expected to see strong colocalization with
PfEBA175, an invasion ligand residing in the micronemes (37–39). Interestingly, we
found that PfCDPK5 did not colocalize as strongly with PfEBA175 as it did with PfAMA1
(Fig. 2A). The limited regions of colocalization seen with high levels of PfCDPK5
expression largely correspond to the diffuse apical staining of PfCDPK5 and not the
more intense punctate regions of PfCDPK5 staining. To conﬁrm this result, we costained
parasites with antibodies against PfAMA1 and PfEBA175. As has been hypothesized
before by epiﬂuorescence and immunoelectron microscopy (40), we found that at
superresolution, these two proteins show limited regions of colocalization and largely
deﬁne different subsets of micronemes (Fig. 2B). Thus, when visualized at superreso-
lution, we found that PfCDPK5 and PfAMA1 colocalize but that PfAMA1 and PfEBA175
appeared in different subsets of micronemes. These results provide further evidence for
the existence of subsets of micronemes in P. falciparum, potentially with different
functions.
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PfCDPK5-deﬁcient parasites do not release micronemes. Studies from both
Plasmodium spp. and T. gondii have demonstrated a role for calcium-dependent protein
kinases in apical organelle discharge. PfCDPK1 has been hypothesized to be important
for microneme discharge (7). However, these experiments relied on chemical and
peptide inhibition of the kinase in extracellular merozoites. In addition, inducible
expression of the PfCDPK1 autoinhibitory junction domain caused a replication defect
at the early schizont stage of P. falciparum (13). A recent characterization of a P. falci-
parum strain with an inducible knockdown of PfCDPK1 demonstrated no detected
defects in parasite egress or PfAMA1 release but did demonstrate decreased invasion
and release of PfEBA175 (41). The Plasmodium berghei ortholog of PfCDPK1 is not
essential for blood-stage replication and therefore unlikely to be essential for mi-
croneme discharge (42). Recently, PfCDPK1 was successfully knocked out in P. falci-
parum, demonstrating that the protein is important but not essential for asexual
growth (43). In T. gondii, CDPK1 (TgCDPK1) (11) and TgCDPK3 (44–46) are essential and
important, respectively, for microneme secretion. Given these precedents, we evaluated
the requirement of PfCDPK5 for microneme secretion.
As noted above, PfAMA1 translocates from micronemes to the plasma membrane of
daughter merozoites during normal parasite egress, and these “post-egress” merozoites
can be obtained by inhibiting red blood cell plasma membrane rupture with E64
treatment (28, 47). Synchronized 3D7-PfCDPK5DDKnL ring-stage parasites were main-
tained in the presence and absence of Shld-1 until 46 h.p.i., E64 was added, and cultures
were incubated for an additional 6 h. Harvested schizonts were evaluated for the
localization of PfAMA1 (Fig. 3A). In schizonts grown in the presence of Shld-1 ([]
FIG 2 Localization of PfEBA175, PfAMA1, and PfCDPK5. (A and B) Schizonts from [] Shld-1 3D7-
PfCDPK5DDKnL parasites were ﬁxed, probed with anti-HA and anti-PfEBA175 (A) or anti-PfAMA1 and
anti-PfEBA175 (B) antibodies, and visualized by SR-SIM. The xz plane and yz plane are shown at the top
and right, respectively, for panel B. The crosshairs indicate one of the limited sites of colocalization. Bars,
2 m.
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FIG 3 PfAMA1 translocation and egress in 3D7-PfCDPK5DDKnL parasites. (A) SR-SIM IFA of [] Shld-1 schizonts or [] Shld-1 schizonts probed with anti-PfAMA1
antibodies. Representative parasites with micronemal and translocated PfAMA1 are shown. Bars, 2 m. (B) Quantiﬁcation of each localization by wide-ﬁeld IFA
from [] or [] Shld-1 schizonts and from [] Shld-1 schizonts treated with 2 M BIPPO shown on the graph. Values are means plus standard deviations (SD)
(error bars). Three biological replicates and 100 schizonts were counted per replicate. Values that were signiﬁcantly different (P  0.0001) by one-way analysis
of variance (ANOVA) are indicated by bars and four asterisks. (C) SR-SIM IFAs performed on [] Shld-1 and [] Shld-1 3D7-PfCDPK5DDKnL schizonts
demonstrating that the localization of PfEBA175 was not different in pre- and post-“egress trigger” [] Shld-1 schizonts or in [] Shld-1 schizonts. (D)
Immunoblot analysis of PfEBA175 processing. [] and [] Shld-1 schizonts were treated with () or without () BIPPO. Equivalent amounts of schizont lysate
and supernatant were subjected to immunoblot analysis with anti-PfEBA175, anti-PfLDH (loading control), and anti-H3 (-Histone 3) (additional loading control)
antibodies. In one set of supernatant samples, the schizonts were allowed to egress naturally without E64. The percentage of schizonts with translocated
PfAMA1 is displayed below the immunoblot (similar to panel B, 100 schizonts counted per condition). (E) Schematic showing the effects of Shld-1, BIPPO, and
compound 1 (C1) on PfAMA1 translocation. PDE, phosphodiesterase. (F) Quantiﬁcation of bioluminescence in supernatant from [] or [] Shld-1 parasites at
50 h.p.i. with or without BIPPO treatment 90 min prior to measurement. Three biological replicates each done with technical triplicates were performed. Values
are means  SD (error bars). Values that are signiﬁcantly different (P  0.0001) by one-way ANOVA are indicated by a bar and four asterisks. Values that are
not signiﬁcantly different by one-way ANOVA (n.s.) are also indicated.
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Shld-1 schizonts), 37%  8% had micronemal PfAMA1, and 63%  8% showed plasma
membrane localization. In sharp contrast, 92%  2% of the schizonts grown in the
absence of Shld-1 ([] Shld-1 schizonts) had micronemal PfAMA1, and only 8%  2%
demonstrated plasma membrane localization (Fig. 3B). It is important to note that the
3D7-PfCDPK5DDKnL parasites allow knockdown but do not completely knock out
PfCDPK5. Thus, we ﬁnd rare [] Shld-1 schizonts with plasma membrane-localized
PfAMA1. These [] Shld-1 schizonts with translocated PfAMA1 may be from residual
low levels of PfCDPK5 or from a less utilized PfCDPK5-independent pathway. Nonethe-
less, these results show a bona ﬁde defect in microneme release in PfCDPK5-deﬁcient
parasites.
To simultaneously evaluate the status of the PfAMA1- and PfEBA175-containing
subsets of micronemes, we costained [] and [] Shld-1 schizonts for the two markers
(Fig. 3C). In both [] and [] Shld-1 schizonts, when PfAMA1 was apical, we found that
PfEBA175 was also apical. Interestingly, in the “post-egress trigger” [] Shld-1 schizonts,
we found that while PfAMA1 had been translocated, on the merozoite surface,
PfEBA175 apparently remained apical. When released, PfEBA175-containing mi-
cronemes expose the ectodomain of PfEBA175 onto the surface of the apical end of the
merozoite. The exposed PfEBA175 is processed by the rhomboid-like protease PfROM4
on the surface of the merozoite, shedding the ectodomain into the culture supernatant
(48, 49). Shedding of processed forms of invasion ligands is detected in the supernatant
from E64-treated schizonts (8). Therefore, to directly evaluate whether PfEBA175-
containing micronemes had been released, we measured the discharge of the pro-
cessed protein into the supernatant. With E64-treated schizonts, we found that pro-
cessed PfEBA175 was readily detected in the supernatant of [] Shld-1 schizonts but
was largely absent from the supernatant of [] Shld-1 schizonts (Fig. 3D). Thus,
although the sensitivity of superresolution microscopy was insufﬁcient to detect dis-
charge of PfEBA175-containing micronemes, their discharge was detected by measure-
ment of the release of the processed form of PfEBA175. Together, these results
demonstrate that the signaling pathways controlling the release of PfAMA1-containing
and PfEBA175-containing micronemes are regulated by PfCDPK5.
Pharmacologically enhanced PKG activity allows for microneme discharge in
PfCDPK5-deﬁcient schizonts. PKG signaling is known to be essential for both exon-
eme and microneme release (8). PKG enzymatic activity is amenable to small-molecule
inhibition and activation in live parasites (schematic in Fig. 3E). The kinase itself is
directly and reversibly blocked by treatment with 4-[2-(4-ﬂuorophenyl)-5-(1-
methylpiperidine-4-yl)-1H-pyrrol-3-yl]pyridine (compound 1 [C1]) (50). In contrast, PKG
activity is enhanced by increasing cyclic GMP levels with the speciﬁc phosphodiesterase
inhibitor 5-benzyl-3-isopropyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one (BIPPO) (51). We
examined whether BIPPO-enhanced PKG activity could overcome the PfCDPK5-
mediated defect in PfAMA1 translocation. Following treatment with 2 M BIPPO,
PfAMA1 translocation was observed in 78%  6% of [] Shld-1 schizonts (Fig. 3B).
Similar to our ﬁndings with PfAMA1, processed PfEBA175 was robustly detected in the
supernatants of both [] and [] Shld-1 schizonts following BIPPO treatment (Fig. 3D).
Utilizing our bioluminescent transgenic reporter parasites (Fig. 1B), we found that
[] Shld-1 parasites, even with a 90% block as schizonts, still release some KnL into
the supernatant. We note that the amount of bioluminescence in the supernatant of
[] Shld-1 parasites was not further decreased when these parasites were treated with
a mixture of protease inhibitors (including serine, cysteine, and metalloprotease inhib-
itors) at 44 h.p.i. (Fig. S3A). Thus, it is likely that the PfCDPK5-deﬁcient arrested schizonts
have partial permeabilization of their surrounding PVM and RBC plasma membrane
that is not dependent on ongoing protease activity. This ﬁnding is consistent with
previous reports that the PVM and RBC plasma membrane of segmented schizonts are
partially permeable to small proteins even in the presence of E64 (8, 28). Nonetheless,
the signiﬁcant difference in the quantity of bioluminescence in the supernatant be-
tween [] and [] Shld-1 schizonts allowed a quantitative measure of membrane
permeability as a surrogate for relative egress efﬁciency. To test whether BIPPO
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activation of PKG induced PfCDPK5-deﬁcient parasites to egress, we measured the
bioluminescence in the supernatant of treated parasites. As expected, the amount of
bioluminescent reporter released into the supernatant from [] and [] Shld-1 para-
sites was equivalent following BIPPO treatment (Fig. 3F). Pretreatment of [] Shld-1
parasites with C1 prior to BIPPO prevented this release (Fig. S3A). For additional
conﬁrmation of this result, we treated PfCDPK5-deﬁcient parasites with zaprinast, a
structurally distinct phosphodiesterase inhibitor that increases cGMP levels and acti-
vates PfPKG, and obtained similar release of bioluminescent activity into the superna-
tant (Fig. S3B). This result demonstrates that enhanced PKG activity induces microneme
secretion and secondarily mediates full permeabilization of the PVM and RBC plasma
membrane.
PKG activity has been linked to downstream calcium release in both Plasmodium
species and T. gondii (52–54). It is formally possible that PKG-induced increases in
cytoplasmic calcium may be sufﬁcient to activate a residual amount of PfCDPK5 in []
Shld-1 parasites. To test whether the BIPPO-induced microneme discharge in PfCDPK5-
deﬁcient parasites was entirely dependent on calcium release, we evaluated PfAMA1
localization (Fig. 4A) and release of the KnL reporter in the supernatant (Fig. 4B) in three
FIG 4 Calcium and cGMP signaling pathways in 3D7-PfCDPK5DDKnL parasites. (A) PfAMA1 translocation was visualized by wide-ﬁeld IFA from [] Shld-1 or []
Shld-1 parasites treated with 1 M A23187 and/or 2 M BIPPO as indicated. Three biological replicates were performed, and 100 schizonts counted per
replicate. Values are means plus SD (error bars). The percentage translocated from the small-molecule-treated [] Shld1 samples was compared to the value
for the untreated [] Shld1 condition by one-way ANOVA. Values that were signiﬁcantly different (P  0.001) by one-way ANOVA are indicated by an asterisk.
Values that were not signiﬁcantly different (#) by one-way ANOVA are also indicated. (B) Bioluminescence activity released in culture supernatants from the
same conditions as in panel A (three biological replicates each done with technical triplicates; mean  SD). Each of the [] Shld1 with small-molecule
treatments was compared to the untreated [] Shld1 condition by one-way ANOVA (*, P  0.001; #, not signiﬁcantly different). (C) 44 h.p.i. schizonts from []
or [] Shld-1 parasites were isolated by magnetic puriﬁcation and lysed immediately or incubated for an 6 additional hours with the indicated compounds prior
to lysis. Protein lysates were subjected to immunoblot analysis with anti-PfMSP142, anti-PfLDH (loading control), and anti-H3 (additional loading control)
antibodies. Full-length, partially processed, and fully processed PfMSP142 are labeled. The quantitative ratio of fully processed PfMSP142 relative to the
unprocessed form was calculated by volumetric measurement of ﬂuorescence intensity with the Li-Cor Odyssey CLx system.
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biological replicates of [] and [] Shld-1 3D7-PfCDPK5DDKnL schizonts treated with
either BIPPO, a calcium ionophore (A23187), or both. In PfCDPK5-deﬁcient schizonts,
A23187 treatment did not induce PfAMA1 translocation, suggesting that calcium
release by itself was not sufﬁcient for microneme discharge. In [] Shld-1 control
parasites, A23187 treatment did not inhibit PfAMA1 translocation, showing that the
elevated level of calcium was not toxic or inhibitory for microneme discharge. This
conclusion is further supported by the observation that the combination of A23187 and
BIPPO in the parasites had the same result as that for BIPPO alone in both [] and []
Shld-1 schizonts. Therefore, the BIPPO-induced microneme release and resulting egress
in PfCDPK5-deﬁcient schizonts are not solely due to a secondary PfPKG-induced
calcium release.
Egress protease cascade is slowed in PfCDPK5-deﬁcient parasites. Previously,
we observed that the egress protease cascade was similarly initiated in both [] and
[] Shld-1 schizonts (15). However, that observation was done using a single time
point. Thus, we evaluated the extent to which the protease cascade in PfCDPK5-
deﬁcient parasites progressed with time—as has been demonstrated for wild-type
parasites (8). For this set of experiments, we chose to use the previously published
3D7-PfCDPK5-DD parasites without an epitope tag (15). This strain was selected,
because it has the strongest replication block of our existing strains. To evaluate the
protease cascade, we focused on PfSUB1 processing of the P. falciparum merozoite
surface protein-1 (PfMSP1), as this protein is known to be important for parasite egress
(20). Following exoneme release, PfSUB1 proteolytically processes the ~200-kDa
PfMSP1 precursor and releases a 42-kDa product, PfMSP142. We isolated 44 h.p.i.
schizonts from parallel cultures that had been maintained with and without Shld-1.
These isolated schizonts were sampled immediately and then allowed to incubate for
an additional 6 h in the presence of E64. As seen previously, PfMSP142 was already
detected at the starting time point in both [] and [] Shld-1 samples (Fig. 4C). In the
[] Shld-1 schizonts, the amount of fully processed PfMSP142 relative to the unpro-
cessed precursor increased from 20% at 44 h.p.i. to 80% 6 h later. In contrast, in the
[] Shld-1 parasites, the relative amount of fully processed PfMSP142 remained 20%
at the later time point.
To evaluate whether exoneme release was completed at the initial time point, []
Shld-1 parasites were treated with C1 to prevent any further PKG activity, and samples
were collected at the later time point. Compared to the untreated [] Shld-1 schizonts
and the starting samples, the relative amount of fully processed PfMSP142 was lower,
indicating that protease processing was incomplete at the starting time point and that
processing required PfPKG activity. As expected, treatment of [] Shld-1 schizonts with
C1 did not change the relative amount of the fully processed PfMSP142. However, when
the [] Shld-1 schizonts were treated with BIPPO, the relative amount of fully processed
PfMSP142 increased to 40% (Fig. 4C). These results demonstrate a previously unrec-
ognized ﬁnding—that protease processing is incomplete in [] Shld-1 schizonts and
that full processing is increased when PfPKG activity is chemically enhanced by BIPPO.
We evaluated PfSERA5, another substrate of PfSUB1 processing (18), in parallel
(Fig. S3C). While the processing differences are smaller, we observed an increase in the
relative amount of the mature (p50/p56) forms of PfSERA5 in the [] Shld-1 schizonts
after 6 h and did not observe the same increase in the [] Shld-1 schizonts (Fig. S3D).
As was seen with PfMSP1, the amount of mature PfSERA5 increased in both [] and []
Shld-1 schizonts following BIPPO treatment.
Physical release of merozoites overcomes microneme release defect. A recently
developed procedure to obtain signiﬁcant quantities of viable merozoites has allowed
for direct studies of mechanically released parasites (27, 55, 56). We have previously
shown that PfCDPK5-deﬁcient merozoites were capable of reinvasion following phys-
ical disruption of the blocked schizonts (15). However, the invasion obtained by this
method was inefﬁcient compared to [] Shld-1 schizonts. We therefore modiﬁed the
published “viable merozoite isolation” (27) procedure to directly evaluate the status of
PfCDPK5 Is Essential for Microneme Release ®
January/February 2018 Volume 9 Issue 1 e00130-18 mbio.asm.org 9
PfCDPK5-deﬁcient merozoites (Fig. 5A). Applying this technique, we found that invasion
efﬁciency of physically released merozoites from [] and [] Shld-1 schizonts was
similar and more robust than previously reported (Fig. 5B). We evaluated PfAMA1
localization in the schizont prior to shearing and in the merozoites following physical
release. Once again, the [] Shld-1 schizonts had populations of both micronemal and
translocated PfAMA1, while [] Shld-1 schizonts had almost exclusively micronemal
localization. Following shearing, translocated PfAMA1 was readily detected on physi-
cally released merozoites from both [] and [] Shld-1 schizonts (Fig. 5C). We repeated
the shearing in the presence of C1 to evaluate whether PfAMA1 translocation induced
by physical release required PfPKG activity. By IFA, PfAMA1 remained micronemal in
released merozoites from C1-treated [] or [] Shld-1 schizonts (Fig. 5C; shown with
nuclear counterstain in Fig. S4). Thus, the process of physical disruption and/or expo-
sure of PfCDPK5-deﬁcient merozoites to the extracellular milieu was sufﬁcient to
facilitate microneme release, as measured by PfAMA1 translocation, and this release
required PfPKG activity. By preventing PfAMA1 translocation, inhibition of PfPKG pre-
vented reinvasion and new ring formation. The mechanism responsible for the en-
hanced PfPKG activity in the sheared merozoites remains unknown. However, these
ﬁndings convincingly demonstrate that a primary role of PfCDPK5 is to trigger mi-
croneme release, allowing parasite egress.
DISCUSSION
PfCDPK5 is essential for P. falciparum egress out of an infected RBC. It localizes to the
apical ends of newly forming daughter merozoites, and in mature, segmented schi-
zonts, PfCDPK5 colocalizes with PfAMA1; later, PfCDPK5 has a diffuse apical staining
FIG 5 Physically released merozoites are invasive. (A) Schematic of the method to generate viable free merozoites
efﬁciently from [] Shld-1 and [] Shld-1 schizonts. 28G, 28-gauge; HCT, hematocrit. (B) Ring parasitemia from
physically released [] or [] Shld-1 schizonts. The ring parasitemia was not different between the [] and []
Shld-1 conditions (n  3; mean  SD; no signiﬁcant difference by Student’s t test). (C) Wide-ﬁeld IFA of PfAMA1
localization before and after shearing from [] and [] Shld-1 parasites. Treatment of schizonts with 2.5 M C1
prior to shearing prevents PfAMA1 translocation.
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that overlaps with several apical markers. PfCDPK5 is present in the membrane-
associated fraction following sodium carbonate extraction, and this localization may be
due to potential palmitoylation sites within the protein (15). However, the trafﬁcking
determinants for PfCDPK5 remain unknown. By superresolution microscopy, we dem-
onstrate multiple nonoverlapping subsets of micronemes. This result has been previ-
ously noted for PfSUB1 (the “exoneme”) and PfROM4 (the “mononeme”) (18, 35).
However, we suggest that the current list of apical organelles should include additional
subsets of egress-speciﬁc micronemes. We hypothesize that a subset of micronemes is
triggered for release by cooperative activation of PfPKG by PfCDPK5. This defect is most
convincingly demonstrated for the PfAMA1-containing micronemes. The complete
identities of which parasite proteins reside in these micronemes remain unknown but
likely include proteases, perforin-like proteins, and potentially other unknown proteins.
We hypothesize that PfCDPK5 interacts with and likely phosphorylates proteins that are
associated with apical organelles to transmit a “release” signal.
We note that parasites physically released following PfPKG-blockade by compound
1 (C1) do not translocate PfAMA1 to the merozoite surface (Fig. 5C; also see Fig. S4 in
the supplemental material) and are, therefore, not invasive. In contrast, PfCDPK5-
deﬁcient parasites can reinvade new RBCs following physical release. Thus, blocking
parasites prior to exoneme release prevents both egress and invasion. Our current
ﬁndings demonstrate an essential role of PfCDPK5 for a downstream release of egress-
mediating micronemes, and we show that chemically enhanced PfPKG activation can
overcome the egress block in PfCDPK5-deﬁcient parasites.
We, therefore, propose a model of egress wherein PfCDPK5 cooperates with PfPKG
activation (Fig. 6). In this model, a basal level of PfPKG activation allows some release
of exonemes and partial activation of the protease cascade. This initial step is inde-
pendent of PfCDPK5. In a later step, PfCDPK5 cooperates with PfPKG to facilitate
PfAMA1 translocation and discharge of micronemes required for egress. This second
step, requiring PfPKG and PfCDPK5, induces full activation of the protease cascade and
allows parasite egress. Finally, supraphysiological activation of PfPKG by BIPPO treat-
ment can bypass the requirement for PfCDPK5. One alternative to the model is that
FIG 6 Model for cooperativity between PfCDPK5 and PfPKG. The progress along the parasite egress
pathway is promoted by activation of PfPKG. At low levels of PfPKG activation, the protease cascade and
calcium signaling pathway are initiated. PfCDPK5 activation, together with PfPKG, leads to further
progression of the protease cascade and triggered release of micronemes required for parasite egress
(detected by PfAMA1 translocation, shown in red). Under physiological conditions, this step requires both
PfCDPK5 and PfPKG. The discharge of micronemes completes the egress process with the release of
invasive merozoites. The requirement for PfCDPK5 can be bypassed by supraphysiological activation of
PfPKG by either BIPPO or physical disruption. PVM, parasitophorous vacuolar membrane.
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PfCDPK5 activity does not affect exoneme secretion directly but rather functions to
increase the efﬁciency and/or completeness of protease processing after exoneme
release.
Our methods to obtain free PfCDPK5-deﬁcient merozoites require either BIPPO (or
zaprinast) treatment or physical disruption. These methods facilitate PfAMA1 translo-
cation and likely the release of other egress-speciﬁc factors. We cannot formally rule out
a role for PfCDPK5 in the invasion process that was not also “overcome” by these
treatments. Nonetheless, PfCDPK5 is the only calcium-dependent protein kinase in
Plasmodium spp. that has a direct role in the release of micronemes required for
parasite egress.
Synergy between calcium-dependent kinases and PKG has been suggested by
previous studies with both T. gondii and Plasmodium parasites (57–59). Our current
results provide strong genetic evidence for this hypothesis. Brochet and colleagues
evaluated the relationship between P. berghei PKG (PbPKG) and calcium signaling,
providing a molecular pathway for connection of the two pathways (52). Alam and
colleagues demonstrated that PfCDPK1 was a likely substrate of PfPKG and that
phosphorylated PfCDPK1 localized to the apical area of daughter merozoites (60).
Bansal and colleagues demonstrated that increased PfPKG activity was able to com-
pensate for a less active PfCDPK1 (57). Similarly, Moon and colleagues demonstrated
that increased PbPKG signaling was able to overcome a defect in gliding motility
observed in PbCDPK3-deﬁcient ookinetes (59). Our current study adds to the complex-
ity of the egress signaling pathway by demonstrating a cooperative relationship
between PfCDPK5 and PfPKG activity.
In summary, we have demonstrated a functional explanation for the egress block
observed in PfCDPK5-deﬁcient parasites. In the absence of normal PfCDPK5 activity,
physiologic activation of the PfPKG pathway is insufﬁcient to release a subset of
micronemes that are essential for parasite egress. Thus, the molecular mechanism for
the egress block observed in PfCDPK5-deﬁcient schizonts is secondary to the failure to
discharge micronemes that are required for egress.
MATERIALS AND METHODS
Small molecules and antibodies. Synthesis of 5-benzyl-3-isopropyl-1H-pyrazolo[4,3-d]pyrimidin-
7(6H)-one (BIPPO) was adapted from published methods (51, 61) and dissolved at 10 mM in dimethyl
sulfoxide (DMSO). See Text S1 in the supplemental material for details. Compound 1 (C1) {4-[2-(4-
ﬂuorophenyl)-5-(1-methylpiperidine-4-yl)-1H-pyrrol-3-yl]pyridine} (50 mM), E64 (10 mM), A23187
(50 mM), and zaprinast (10 mg/ml) were dissolved in DMSO. Commercially available antibodies were
obtained from Roche Applied Science (rat antihemagglutinin [anti-HA] [3F10]), Life Technologies (mouse
anti-HA [clone 2-2.2.14]), and Abcam (rabbit anti-H3). Other antibodies were generously provided by
Michael Makler at Flow Inc. (mouse anti-P. falciparum lactate dehydrogenase [anti-PfLDH]), Julian Rayner
at the Wellcome Trust Sanger Institute (rabbit anti-PfGAP45), Robin Anders at The Walter & Eliza Hall
Institute of Medical Research (mouse anti-PfAMA1 [clone 1FG]), Jean-Francois Dubremetz at Universitè
Montpellier (mouse anti-PfSERA5 [clone 24C6.1F1]), Alan Cowman, Jenny Thompson, and Kaye Wycher-
ley at The Walter & Eliza Hall Institute of Medical Research (rabbit anti-PfEBA175 and mouse anti-PfRON4),
Michael Blackman at the London School of Hygiene and Tropical Medicine and the Francis Crick Institute
(rabbit anti-PfSUB1), Carole Long at NIAID, NIH (rabbit anti-PfMSP142), and Kim Lee Sim via BEI Resources,
NIAID, NIH (mouse anti-PfEBA175 [clone R218]).
Parasite culture and transfection. The 3D7 strain (Walter & Eliza Hall Institute) and transgenic
derivatives were cultured in human red blood cells (RBCs) in RPMI 1640 supplemented with 0.5%
Albumax II, 50 mg/liter hypoxanthine, 0.21% sodium bicarbonate, and 25 mM HEPES as previously
described (62). To generate the 3D7-PfCDPK5DD strain, sorbitol-synchronized ring-stage parasites were
electroporated with 100 g of plasmid DNA of the single-crossover plasmid (see Text S1 for details).
Following transfection, parasites were maintained with 250 nM Shield-1 (Shld-1), and stable single-
crossover parasites were selected by cycling on and off WR99210 (Jacobus Pharmaceutical Company).
Individual transgenic clones were obtained by limiting dilutions. To generate the 3D7-PfCDPK5DDKnL
parasites with the KnL reporter, a clone was transfected with pJDD250 that expresses the Bxb1 integrase
(23) and the KnL reporter and selected on blasticidin (while maintaining WR99210 and Shld-1).
Parasite phenotypic assays. For replication curves, ring-stage parasites were washed to remove
Shld-1, replated in the presence or absence of 0.25 mM Shld-1 at 0.4% parasitemia and 1% hematocrit,
and parasitemia was monitored by ﬂow cytometry using SYBR green I staining. For measurements of
bioluminescence throughout the asexual development cycle, 100 l of resuspended culture was
removed from ring, trophozoite, schizont, and reinvaded rings and centrifuged at 14,000 rpm in a
microcentrifuge. The supernatant was transferred to a fresh tube, and 20 l was mixed 1:1 with nano-Glo
buffer/substrate (Promega). The pelleted cells were resuspended in 100 l of phosphate-buffered saline
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(PBS), and then 20 l of the PBS solution containing cells was mixed 1:1 with nano-Glo buffer/substrate.
Light output was measured on a SpectraMax L instrument.
For all indirect immunoﬂuorescence assays (IFAs), parasites were synchronized by Percoll puriﬁcation
of late-stage schizonts, followed by sorbitol synchronization of newly invaded rings 2 h later. In the
following cycle, sorbitol synchronization was repeated, and the cultures were washed and replated with
or without Shld-1. IFAs were performed as previously described (47) with minor modiﬁcations. Thin
smears were made on glass slides, air dried, and ﬁxed with 1% paraformaldehyde, permeabilized with
0.1% Triton 100 for 10 min, and blocked with 3% bovine serum albumin (BSA) overnight at 4°C. Primary
antibodies were incubated overnight in a cold room at the dilutions indicated: anti-PfAMA1 (1:200),
anti-PfEBA175 (1:500), anti-PfGAP45 (1:5000), anti-HA (1:50), anti-PfSUB1 (1:500), and anti-PfRON4 (1:200).
Subsequently, cells were washed three times with PBS and incubated for 45 min with the Alexa Fluor 488
or 555 secondary antibodies (1:1,000) (Molecular Probes). After removal of unbound antibodies with
three PBS washes, slides were mounted with Vectashield containing 4=,6=-diamidino-2-phenylindole
(DAPI) (Vector Laboratories Inc.) with coverslips and kept at 4°C until evaluation. Wide-ﬁeld images were
obtained with a Nikon E800 epiﬂuorescence microscope using a 100 (oil) objective, and images were
captured using SPOT Imaging software and then processed using Adobe Photoshop. Superresolution
structured illumination microscopy (SR-SIM) Z-stacks were captured using an ELYRA PS.1 microscope
(Carl Zeiss Microscopy). The ELYRA microscope was used with a 100 (oil) objective and excitation
wavelengths of 405, 488, and 561 nm. SIM images were collected at 100- to 200-nm z-axis steps, with ﬁve
rotations of the structured illumination grid per channel. The resulting stacks were processed using
default reconstruction parameters in ZEN 2012 Black software.
For the P. falciparum AMA1 (PfAMA1) translocation IFAs shown in Fig. 3, 10 M E64 was added to the
schizonts 46 h postinvasion (h.p.i.) and incubated for 4 h, then 2 M BIPPO was added for an additional
2 h, and schizonts were harvested for analysis. For the bioluminescence and PfAMA1 translocation IFAs
shown in Fig. 4, 10 M E64 was added to 46 h.p.i. schizonts and incubated for 150 min, 1 M A23187
(or nothing) was added for 90 min, then 2 M BIPPO was added for 2 h, and schizonts/supernatants were
harvested for analysis. A total of 100 schizonts were scored for micronemal or plasma membrane
translocation, and bioluminescence was measured as described above. For PfEBA175 processing exper-
iments, synchronized ring-stage parasites were washed three times to remove Shld-1, and grown at 4%
hematocrit in the presence and absence of 250 nM Shld-1. At 44 h.p.i., schizonts were puriﬁed by passage
through a magnetically activated cell sorting (MACS) column, spun down to a pellet, and resuspended
in 100 l of medium containing 10 M E64 in the presence or absence of Shld-1, and plated in a 96-well
plate. Heparin (50 g/ml) was added to all wells to prevent reinvasion. BIPPO (2 M) was added 4 h after
plating, and parasites were collected 2 h after the addition of BIPPO. Samples were spun down to
separate supernatant and pellet. Parasite pellets were washed once with RMPI 1640, and supernatants
were spun again to clear any remaining parasites. Washed pellets and cleared supernatants were boiled
in sample buffer, analyzed by immunoblotting with anti-PfEBA175 antibodies or anti-PfLDH and anti-H3
antibodies to control for loading, probed with Li-Cor secondary antibodies, and visualized on a Li-Cor
Odyssey CLx system. Concurrently, samples of parasites were prepared for immunoﬂuorescence assays
by preserving 300 l each of Shld-1 cultures grown with Shld-1 ([] Shld-1 cultures) and Shld-1 cultures
grown without Shld-1 ([] Shld-1 cultures) prior to MACS puriﬁcation. Cultures were plated along with
MACS-puriﬁed schizonts, and samples were treated as described above. At the time of sample collection,
cultures were spun down, and smears were made from the RBC pellet. IFA preparation was performed
as described above, and PfAMA1 translocation was determined.
For PfMSP1 and PfSERA5 processing assays, 44 h.p.i. schizonts from [] and [] Shld-1 cultures were
puriﬁed by magnetic separation, placed in medium without Albumax II with or without Shld-1. A sample
of the puriﬁed schizonts were lysed immediately in sample buffer, and the remaining schizonts were
incubated for an additional 6 h before harvesting. E64 (10 M) was added to all samples at 44 h.p.i. (for
C1-treated samples, 2.5 M C1 was also added). At 48 h.p.i., 2 M BIPPO was added to indicated samples.
All treated samples were lysed at 50 h.p.i. Lysates were separated on a TGX 4 to 20% gradient cell
(Bio-Rad), transferred to polyvinylidene diﬂuoride (PVDF) by wet transfer, immunoblotted with rabbit
anti-PfMSP142 or mouse anti-PfSERA5 (and anti-PfLDH and anti-H3 as loading controls), probed with
Li-Cor secondary antibodies, and visualized on a Li-Cor Odyssey CLx system.
For physical disruption assays, viable merozoites were performed as previously described (27, 55)
with minor modiﬁcations. Late-stage schizonts were magnet puriﬁed, incubated in medium with 10 M
E64 and without Albumax II for 6 h, and sheared with 20 strokes through a 28-gauge needle. The sheared
merozoites were incubated with or without fresh RBCs at 37C for 15 min. Reinvasion was determined by
ﬂow cytometry, and PfAMA1 translocation was determined by IFA.
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